SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation

NCT01053962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: SP-304 0.3 mg
DRUG: SP-304 1.0 mg
DRUG: SP-304 3.0 mg
DRUG: SP-304 9.0 mg
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.